Gene Biotech
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
GeneBioTechCo is a consumer staples company listed on KOSDAQ, South Korea's technology and small-cap exchange.
Based on its sector classification, it operates in food, beverages, household products, or related consumer goods. The filing's business description does not provide sufficient detail to identify specific products, customers, or a clear structural fact about the business.
Summary is AI-generated and may contain errors · figures from DART filings
Gene Biotech in five facts
What does Gene Biotech do?
GeneBioTechCo is a consumer staples company listed on KOSDAQ, South Korea's technology and small-cap exchange.
Where is Gene Biotech listed and in which sector?
Gene Biotech (Korean name: 진바이오텍) trades under KRX code 086060 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Staples Retail.
How large is Gene Biotech?
Its market capitalisation was US$32.4M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Gene Biotech's latest annual revenue and operating profit?
For fiscal year 2025, Gene Biotech reported revenue of US$68.5M, operating profit of US$3M and net income of US$2.9M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 9.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Cash/in-kind dividend decision (interim dividend)
Gene Biotech updated its declared cash dividend of US$0.02 per share, equal to about 0.6% of the recent share price.
Dividend · Oct 14 · 2 versions - DisclosureOct 14
- Cash/in-kind dividend decision
Gene Biotech declared a cash dividend of US$0.03 per share.
Dividend · Feb 6 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Gene Biotech reported consolidated results for FY2025: revenue of US$61.7M (+9.4% year on year), operating profit of US$2.67M (+2% year on year) and net income of US$2.58M (+32.2% year on year).
Earnings · Feb 6